CoChat

Pilot trial of gabapentin for the treatment of benzodiazepine abuse or dependence in methadone maintenance patients

Open access

The DOI matches its Crossref record; 70 of the 70 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Benzodiazepine use disorders are a common clinical problem among methadone maintenance treatment patients and have adverse effects on clinical outcomes. OBJECTIVES: To evaluate gabapentin for the outpatient treatment of benzodiazepine abuse or dependence in methadone maintenance patients. METHODS: Participants (n = 19) using benzodiazepines at least 4 days per week were enrolled into an 8-week randomized double-blind placebo-controlled outpatient pilot trial. All participants received a manual-guided supportive psychotherapy aimed to promote abstinence. Study medication was titrated over a 2-week period to a maximum dose of gabapentin 1200 mg or placebo three times a day. Benzodiazepine use was assessed using urine toxicology confirmed self-report. Benzodiazepines were not provided as part of study participation; participants were provided guidance to gradually reduce benzodiazepine intake. RESULTS: Sixteen participants had post-randomization data for analysis. Retention at week eight was 50%. The mean dose of gabapentin achieved by titration was 2666 mg/day (SD = ± 1446). There were no significant between group differences on benzodiazepine use outcomes (amount benzodiazepine per day [Mann-Whitney U = 27, p = 0.745], abstinent days per week [U = 28, p = 0.811]) and Clinical Instrument Withdrawal Assessment (CIWA)-benzodiazepines scale (U = 29.0, p = 0.913). One participant in the gabapentin group discontinued study medication because of peripheral edema. Two participants in the placebo group requested admission for inpatient detoxification treatment. CONCLUSION: In outpatient methadone-maintained patients with benzodiazepine use disorder, gabapentin did significantly decrease benzodiazepine use relative to placebo. The small sample recruited for this trial may have limited the ability to detect a group difference.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3109/00952990.2015.1125493

Cites

70 of 70 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Show all 70 references

Research works printed but not linked: 13

  1. Bleich A, 1999, A 1 year prospective study in an Israeli clinic. Addiction, 94, 1533
  2. Bleich A, 2002, Isr J Psychiatry Relat Sci, 39
  3. Caplehorn JR, 2002, Aust N Z J Public Health, 26, 362
  4. Eiroa-Orosa FJ, 2010, methadone maintenance treatment: findings of the German randomized controlled trial. Drug Alcohol Depend, 112, 226
  5. Cantopher T, 1990, A comparative study of abrupt withdrawal under propranolol cover versus gradual withdrawal. Br J Psychiatry, 156, 406
  6. Hallstrom C, 1988, Postgrad Med J, 64, 40
  7. Lemoine P, 1997, A controlled study, hydroxyzine versus placebo]. L’Encephale, 23, 290
  8. Stitzer M, 1982, NIDA Res Monogr, 41, 282
  9. 10.1037/0022-006X.60.6.927 · DOI · Paper page
  10. 10.1042/bj3420313 · doi:10.1042/bj3420313 · Paper page
  11. Wang PW, 2002, Psychopharmacol Bull, 36, 44
  12. Salinsky MC, 2002, Epilepsia, 43482
  13. Carroll KM, 1999, West Haven, CT: Yale University Psychotherapy Development Center Training Series No, 4

Cited by

See all 27

Metadata

Authors
Mariani, J. J., Malcolm, R. J., Mamczur, A. K., Choi, J. C., Brady, R., Nunes, E., & Levin, F. R.
Affiliations
  • New York State Psychiatric Institute (US)
  • Medical University of South Carolina (US)
  • Narco Freedom (United States) (US)
Corresponding author
Mariani, John J.
Venue
The American Journal of Drug and Alcohol Abuse
Published
2016-03-10
Volume
42
Issue
3
Pages
333-340
ISSN
  • 0095-2990 (ISSN-L)
  • 1097-9891
OpenAlex
W2301693649
Cited by
27
References
70
Citations by year
2026: 1 · 2024: 4 · 2023: 1 · 2022: 2 · 2021: 6 · 2020: 4 · 2019: 3 · 2018: 4 · 2017: 2
FWCI
2.98
Type
journal article
Language
en
Open access
Locations
  • The American Journal of Drug and Alcohol Abuse (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
National Institute on Drug Abuse (K23-DA021209, K24 029647, K24-DA022412, P50-DA09236)
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
  • Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
  • Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
Keywords
gabapentin, benzodiazepine use disorder, benzodiazepine dependence, benzodiazepine misuse, methadone maintenance treatment, opioid use disorder, outpatient care, supportive therapy, benzodiazepine withdrawal, abstinence
MeSH terms
Gabapentin, Adolescent, Adult, Aged, Amines, Benzodiazepines, Combined Modality Therapy, Cyclohexanecarboxylic Acids, Double-Blind Method, Female, gamma-Aminobutyric Acid, Humans, Male, Methadone, Middle Aged, Pilot Projects, Psychotherapy, Substance Withdrawal Syndrome, Substance-Related Disorders, Young Adult, Opiate Substitution Treatment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Pilot trial of gabapentin for the treatment of benzodiazepine abuse or dependence in methadone maintenance patients. https://app.cochat.ai/papers/10.3109/00952990.2015.1125493
The paper
Mariani, J. J., Malcolm, R. J., Mamczur, A. K., Choi, J. C., Brady, R., Nunes, E., & Levin, F. R. (2016). Pilot trial of gabapentin for the treatment of benzodiazepine abuse or dependence in methadone maintenance patients. The American Journal of Drug and Alcohol Abuse. https://doi.org/10.3109/00952990.2015.1125493

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.